Phoenix Life Sciences International Limited
PLSI · OTC
2/28/2019 | 11/30/2018 | 8/31/2018 | 5/31/2018 | |
|---|---|---|---|---|
| Market Cap | $367 | $1,009 | $308 | $369 |
| - Cash | $202 | $7 | $1 | $1 |
| + Debt | $36 | $0 | $0 | $0 |
| Enterprise Value | $201 | $1,002 | $307 | $368 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $201 | -$3,131 | -$25 | -$131 |
| % Margin | – | – | – | – |
| Net Income | $205 | -$2,888 | -$294 | -$140 |
| % Margin | – | – | – | – |
| EPS Diluted | 5.87 | -82.56 | -8.4 | -4.01 |
| % Growth | 107.1% | -882.9% | -109.5% | – |
| Operating Cash Flow | -$311 | -$549 | -$269 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$311 | -$549 | -$269 | -$0 |